1Hamburger AW, Salmon SE. Primary bioassay of human tumor stem cells[J]. Science, 1977,197(4302) :461 -463.
2Creker AK, Goodale D, Chu J, et al. High aldehyde dehydregenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability[ J]. J Cell Mol Med, 2009,13 (8 B) :2236-2252.
3A1-Hajj M, Wieha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells[ J]. Proc Natl Acad Sei U S A, 2003,100(7) :3983 -3988.
4Ponti D, Costa A, Zaffaroni N, et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/pregenitor cell properties [ J]. Canfer Res ,2005,65 ( 13 ) :5506-5511.
5Sheridan C, Kishimoto H, Fuehs RK, et al. CD44 -/CD24-breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis [ J ]. Breast Cancer Res, 2006,8 (5) :R59.
6Nakshatri H, Srour EF, Badve S. Breast cancer stem cells and intrinsic subtypes: eontreversies rage on [ J ]. Curr Stem Cell Res Ther, 2009 ,4(1) :50 -60.
8Madjd Z, Mehrjerdi AZ, Sharifi AM, et al. CD44+ cancer cells ex press higher levels of the anti-apoptotic protein Bcl-2 in breast tumours[ J]. Cancer Immun ,2009,9:4.
9Bircan S, Kapucuoglu N, Baspinar S, et al. CD24 expression in duc tal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study [ J ]. Pathol Res Pract, 2006,202(8) :569 -576.
10Birean S, Kapucuoglu N, Baspinar S, et al. CIY24 expression in duc tal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study [ J ]. Pathol Res Pract, 2006,202 ( 8 ) :569-576.
3Gil J, Stembalska A, Pesz KA, et al. Cancer stem cells: the theory and perspectives in cancer therapy [ J]. J Appl Genet, 2008,49 (2) :193 - 199.
4Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells [J]. Proc Natl Acad Sci U S A, 2003,100(7):3983-3988.
5Croker AK, Goodale D, Chu J, et al. High aldehyde dehydrogenase and expression of cancer stein cell markers selects for breast cancer cells with enhanced malignant and metastatic ability [ J ]. J Cell Mol Med, 2008,4 (4) : 1 -43.
6Pacheco MM, Nishimoto IN, Mour? o Neto M, et al. Prognostic significance of the combined expression of matrix metalloproteinase-9, urokinase type plasminogen activator and its receptor in breast cancer as measured by Northern blot analysis [ J ]. Int J Biol Markers, 2001,16 (1) :62 -68.
7Tavassoeli F A, Devilee P. Pathology and Genetics Tumours of the Breast and Female Genital Organs [ M ]. Lyon : IARC Press, 2003 : 10.
8Strobel T, Swanson L, Cannistra SA. In vivo inhibition of CD44 limits intra-abdominal spread of a human ovarian cancer xenograft in nude mice: a novel role for CD44 in the process of peritoneal implantation [ J]. Cancer Res, 1997, 57(7) :1228 - 1232.
9Madjd Z, Mehrjerdi AZ, Sharifi AM, et al. CD44^+ cancer cells express higher levels of the anti-apoptotic protein Bcl- 2 in breast turnouts [J]. Cancer Immun, 2009, 23(9) :4 -11.
10Bircan S, Kapucuoglu N, Baspinar S, et al. CD24 expression in duetal carcinoma in situ and invasive duetal carcinoma of breast: an immunohistochemistry-based pilot study [ J ]. Pathol Res Praet, 2006,202 ( 8 ) :569 - 576.
1Bonito MD, Cantile M, Malzone G, et al. The prognostic role of cancer stem cells in breast tumors [ J]. J Clin Med Res, 2013,5 (5) :325 -326.
2McClements L, Yakkundi A, Papaspyropoulos A, et al. Targeting treatment-resistant breast cancer stem cells with FKBPL and its peptide derivative, AD-O1, via the CIM4 pathway[ J]. Clin Cancer Res ,2013,19 (14) :3881 - 3893.
3Drescher CW, Shah C, Thorpe J, et al. Longitudinal screening al- gorithm that incorporates change over time in CA125 levels identi- fies ovarian cancer earlier than a single -threshold rule[ J]. J Clin Oneol, 2013, 31(3): 387-392.
4Charafe - Jauffret E, Ginestier C, Bertucci F, et al. ALDH1 - pos- itive cancer stem cells predict engraftment of primary breast tumors and are governed by a common stem cell program[J]. Cancer Res, 2013, 73(24): 7290-7300.
5Ataseven H, Oztiirk ZA, Arhan M, et al. Cancer antigen 125 lev- els in inflammatory bowel diseases[ J]. J Clin Lab Anal, 2009, 23 (4) : 244 -248.
6NeeshamD. Ovarian cancer screening [ J ]. Aust Fam Physician, 2007, 36(3) : 126 -128.
8Kawakami Y, Matsushita M, Ueda R, et al. Immunotherapy targe- ting cancer stem cells[J]. Nihon Rinsho, 2012, 70(12) : 2142 - 2146.
9Kim SK, Kim H, Lee DH, et al. Reversing the Intractable Nature of Pancreatic Cancer by Selectively Targeting ALDH - High, Thera- py - Resistant Cancer Cells [J]. PLoS One, 2013, 8 (10) : e78130.
10Xu Z, Shen Z, Shi L, et al. Aldehyde dehydrogenase 1 expression correlated with malignant potential of oral lichen planus [ J ]. Ann Diagn Pathol, 2013,17(5) : 408 -411.
